Your browser doesn't support javascript.
loading
Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL.
Stein, Sarah J; Mack, Ethan A; Rome, Kelly S; Pajcini, Kostandin V; Ohtani, Takuya; Xu, Lanwei; Li, Yunlei; Meijerink, Jules P P; Faryabi, Robert B; Pear, Warren S.
Afiliação
  • Stein SJ; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Mack EA; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Rome KS; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Pajcini KV; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Ohtani T; Department of Pharmacology, University of Illinois at Chicago, Chicago, IL, United States of America.
  • Xu L; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Li Y; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Meijerink JP; The Department of Pediatric Oncology/Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Faryabi RB; The Department of Pediatric Oncology/Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Pear WS; Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Institute of Medicine and Engineering, Institute for Immunology, Center for Personalized Diagnostics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
PLoS One ; 11(5): e0155408, 2016.
Article em En | MEDLINE | ID: mdl-27191957
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas Serina-Treonina Quinases / Peptídeos e Proteínas de Sinalização Intracelular / Receptores Notch / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Proteínas Serina-Treonina Quinases / Peptídeos e Proteínas de Sinalização Intracelular / Receptores Notch / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2016 Tipo de documento: Article